Investor Presentaiton

LOVVOLUS JEUVEAU EXTRA-STRENGTH PHASE II DURATION STUDY EFFICACY: NONE OR MILD GLABELLAR LINE NONE OR MILD GLABELLAR LINE SCALE AT MAXIMUM FROWN INVESTIGATOR ASSESSMENT SUBJECT ASSESSMENT % Responders ཱ ཞ ཆ ➢ ྴ ¥ ཞ རྨུ ཋ。 100 100 De 90 80 70 No data collected Between Day 2 and Day 30 % Responders 60 50 40 30 ◆ No data collected Between Day 2 and Day 30 20 10 0 0 30 60 90 120 150 Days After Treatment 180 210 240 270 300 330 360 0 30 60 90 120 150 180 210 240 270 300 330 360 Days After Treatment -Ona 20U -Pra 20U -- Pra 40U -Ona 20U -Pra 20U -- Pra 40U STUDY COMPLIANCE Subjects completing study: 94.7% (144/152) Prabot 40U 96.1 (49/51) Prab 20U 92.2% (47/51) Ona 20U 96.0% (48/50) 24

View entire presentation